Christian Schutz
Saarbruecken, SL 66123, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration.
Journal: Journal of medicinal chemistry
Published: February 05, 2026
Innovative zinc-binding inhibitors of Legionella pneumophila ProA reduce collagen and flagellin degradation, TLR5 evasion, and human lung tissue inflammation.
Journal: European journal of medicinal chemistry
Published: January 23, 2025
Dipeptidic Phosphonates: Potent Inhibitors of Pseudomonas aeruginosa Elastase B Showing Efficacy in a Murine Keratitis Model.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 24, 2024
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicity.
Journal: European journal of medicinal chemistry
Published: April 07, 2024
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 03, 2022
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR.
Journal: European journal of medicinal chemistry
Published: March 25, 2021
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 13, 2020
Targeting the Pseudomonas quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers.
Journal: Beilstein journal of organic chemistry
Published: July 31, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026